Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP1226 | DOI: 10.1530/endoabs.99.EP1226

ECE2024 Eposter Presentations Late Breaking (127 abstracts)

Assessment of sarcopenia in patients with diabetes mellitus, considering body composition

Elena Makhlina 1 , Yana Navmenova 1 , Oksana Kononova 1 & Tatiana Mohort 2


1Gomel State Medical University, Chairs Internal Medicine No. 1 with courses in endocrinology and hematology, Gomel, Belarus; 2Minsk, Endocrinology, Minsk, Belarus


Objective: To assess the features of the manifestation of sarcopenia (SP) in patients with diabetes mellitus (DM), taking into account the body composition.

Materials and study methods: The study included 87 patients with DM (29 men - 33% and 58 women - 67%). The average age of patients was 41.59±11.84 years and duration of diabetes was 12.51±6.39 years. The study included anthropometric measurements: mass body index (BMI), waist circumference (WC), shin circumference (SC). Muscle strength (MS) was determined using hand dynamometry, and muscle function (MF) was assessed using a 4-meter walking speed test. Taking into account WC, patients were divided into 2 groups: the first group (n=45) WC less than 80 cm for women and less than 94 cm for men and the second group (n=42) with WC exceeding these target parameters taking into account gender. Statistical processing of the data array was performed using the statistical program «Statistica 10.0» (StatSoft, GS35F-5899H). The level P<0.05 is considered as a criterion for the statistical confidence of the results.

Study results and discussion: When assessing SP parameters in patients with DM, the groups differed significantly in muscle mass (MM) assessed by SC (SC first group 35.00 [34.00; 36.00]cm, second group 38.00 [37.00; 39.00] cm) and MF (first group 4.00 [4.00; 4.00] points, second group 3.00 [3.00; 4.00] points ) P<0.05. There were no significant differences in MS between the groups (first group 27.27 [20.50; 37.00] kg, second group 21.00 [18.00; 31.50] kg) P>0.05. There was a decrease in MM in 14% of patients in the first group and in 8% of patients in the second group. A decrease in MF prevailed in patients in the second group (62%), while in the first group a decrease in MF was not noted. The decrease in MS prevailed in patients in the second group (first group – 29%, second group – 46% of patients) P<0.05.

Conclusions: Decreased MS (46% of patients) in patients with DM, which determines the probability of SP, and decreased MF (62% of patients) were noted in patients with WC and BMI exceeding the target values, and decreased MM prevailed in patients with WC and BMI corresponding to the target normal values.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.